WEST PHARMACEUTICAL SERVICES INC 4

Annette F. Favorite, Sr. VP & Chief HR Officer of West Pharmaceutical Services, Inc., exercised 8,135 stock options and sold 8,135 shares of common stock on September 8, 2026 for roughly $2.8 million in gross proceeds.

On September 8, 2026, Annette F. Favorite, Sr. VP & Chief HR Officer of West Pharmaceutical Services, Inc., exercised three tranches of stock options (2,817 shares at $83.47, 2,818 shares at $83.47, and 2,500 shares at $89.64) and immediately sold an equal number of common shares (2,817 + 2,818 + 2,500) at a weighted average price of $340.81 per share in a series of same‑day transactions. The option exercises were reported at the stated strike prices (with $0 in Column 4 for the derivative line items) and resulted in a net gain capture while keeping her direct ownership roughly stable at 16,844.5548 shares immediately after the paired exercise-and-sale events, before a final derivative exercise sequence that shows 7,524 shares owned directly at the end of the reported derivative transactions. Based on the indicated sale price and the company’s current trading price, the gross sale proceeds for the 8,135 shares sold were approximately $2.77 million, reflecting a sizable but largely cashless, pre‑planned liquidity event tied to long‑term option awards granted in 2017 and 2018 that vested in four annual installments.

Filing Facts

CIK

105770

Ticker

WST

Form

4

Source Type

fda

Accession

0000105770-26-000108

Alert Tier

7